- Investing Ideas
- /
- Global Small Cap High Growth Stocks
Global Small Cap High Growth Stocks
UPDATED Apr 27, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
2,385 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
HHR | AU$0.007 | -12.5% | -79.4% | AU$19.7m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
RDUE | €9.50 | 0% | 2.6% | €59.4m | €10.50 | PE17.5x | E37.7% | n/a | Capital Goods | ||
ATAKP | ₺47.56 | 5.5% | n/a | ₺6.6b | ₺67.66 | PE22.3x | E72.8% | n/a | Food, Beverage & Tobacco | ||
CALTX | kr103.70 | 3.2% | -16.7% | kr5.6b | kr208.00 | PS4.6x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
GIG | kr32.80 | -3.7% | 19.9% | kr4.2b | kr49.20 | PE26.8x | E39.8% | n/a | Consumer Services | ||
FDE | €33.70 | 3.7% | -3.6% | €176.3m | €64.07 | PE22.4x | E37.6% | n/a | Energy | ||
KEBNI B | kr1.62 | 7.1% | 33.2% | kr439.8m | kr1.80 | PS6.1x | E96.2% | n/a | Tech | ||
NVG | zł2.08 | -7.1% | 30.0% | zł72.8m | zł3.71 | PE7.5x | E28.5% | n/a | Diversified Financials | ||
NEWBRY | kr3.41 | -2.6% | -40.2% | kr82.7m | kr8.00 | PS3.6x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
MVW | kr8.75 | 4.2% | 14.2% | kr286.3m | kr13.00 | PS26x | E66.8% | n/a | Materials | ||
GWIND | ₺28.20 | 2.4% | 81.8% | ₺15.2b | ₺39.79 | PE24.4x | E60.9% | 1.6% | Utilities | ||
NOHAL | kr22.00 | -0.9% | -12.7% | kr860.3m | kr32.50 | PS8.4x | E56.0% | n/a | Food, Beverage & Tobacco | ||
ELABS | kr15.96 | 9.3% | 36.2% | kr1.7b | kr25.00 | PS24.5x | E124.6% | n/a | Software | ||
OSE | €5.56 | 3.3% | 37.3% | €119.9m | €7.15 | PS53.9x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
ADOC | €8.43 | -0.2% | 194.8% | €120.5m | €9.70 | PS19.9x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
WAYS | kr23.20 | 0.7% | -55.0% | kr187.2m | kr39.75 | PS1.7x | E81.8% | 0% | Tech | ||
ZVRA | US$4.52 | 0% | -16.3% | US$189.2m | US$19.00 | PS6.9x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
AGP | €7.64 | 4.9% | 101.6% | €132.3m | €12.75 | PE26.9x | E22.8% | n/a | Capital Goods | ||
RCEL | US$8.52 | -1.4% | -45.1% | US$219.8m | US$26.43 | PS4.4x | E61.1% | n/a | Pharmaceuticals & Biotech | ||
APLT | US$4.28 | -2.3% | 151.8% | US$489.0m | US$11.60 | PS48.9x | E81.9% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$3.99 | -2.9% | 39.0% | US$208.3m | US$8.50 | PS2.5x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
AVLL3 | R$3.61 | 2.6% | 33.2% | R$705.1m | R$9.90 | PS1.5x | E101.9% | n/a | Consumer Durables | ||
FWRY | ج.م6.10 | -14.1% | 2.3% | ج.م20.8b | ج.م7.20 | PE33.6x | E34.8% | n/a | Diversified Financials | ||
A211050 | ₩4,900.00 | 0% | 120.1% | ₩241.6b | ₩3,800.00 | PE8.2x | E41.8% | 1.4% | Insurance |